Create registry of Childhood Cancer patients in India with COVID 19 to provide guidelines for prevention and treatment
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2020/05/025221
- Lead Sponsor
- Dr Ramandep Arora
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All children who at diagnosis of their cancer were < 18 years of age
2. They are now either on therapy including chemotherapy, immunotherapy, radiotherapy and surgery, or have completed therapy
3. Confirmed diagnosis of COVID-19 by RT-PCR or antibody test
4. Located in India at the time of the diagnosis of COVID-19
Exclusion Criteria
1. Those who refuse consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality rate at 30 days from diagnosis of COVID-19 Treatment abandonment rates at 90 days from diagnosis of COVID-19 <br/ ><br>Timepoint: Day 30 <br/ ><br>Day 90
- Secondary Outcome Measures
Name Time Method 1.Requirement for hospitalization to manage COVID-19, length of hospital stay <br/ ><br>2.Requirement for intensive care to manage COVID-19 or comorbidities, length of ICU stay <br/ ><br>3.Duration of suspended chemotherapy due to COVID-19 (for patients on therapy) <br/ ><br>4.Delays in anti-cancer treatment (chemotherapy, radiation therapy, surgery, other therapies) due to COVID-19 <br/ ><br>5.Rate of refractory/progression/relapse diseaseTimepoint: Day 30 <br/ ><br>Day 90